pyrazines has been researched along with Hyperplasia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, M; Butler, AE; Butler, PC; Campbell-Thompson, M; Dawson, DW; Gurlo, T | 1 |
| Harja, E; Lord, J; Skyler, JS | 1 |
| Bi, YW; Gu, XH; He, XP; Li, XX; Pang, XY; Sun, WY; Yue, WM | 1 |
| Denda, M; Denda, S; Tsutsumi, M | 1 |
| Morris, AP; Sellin, JH; Umar, S; Wang, Y | 1 |
| Chen, L; Chen, Z; Ding, S; Feng, Y; Ma, G; Shen, C | 1 |
| Furukawa, F; Ikezaki, S; Kasahara, K; Lee, IS; Nishikawa, A; Takahashi, M; Tanakamura, Z | 1 |
| Haddow, A; Ross, WC; Timmis, GM | 1 |
8 other study(ies) available for pyrazines and Hyperplasia
| Article | Year |
|---|---|
Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.
Topics: Adenoma; Adolescent; Adult; Aged; Cell Proliferation; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hyperplasia; Incretins; Insulin-Secreting Cells; Male; Middle Aged; Neuroendocrine Tumors; Organ Size; Pancreas; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology.
Topics: Adolescent; Adult; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hyperplasia; Hypoglycemic Agents; Incretins; Male; Middle Aged; Models, Statistical; Pancreas; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Tissue Banks; Triazoles; Venoms; Young Adult | 2013 |
The proteasome inhibitor bortezomib inhibits intimal hyperplasia of autologous vein grafting in rat model.
Topics: Animals; Boronic Acids; Bortezomib; DNA Primers; Gene Expression Regulation; Hyperplasia; Interleukins; Jugular Veins; Male; Models, Animal; Protease Inhibitors; Pyrazines; Rats; Rats, Wistar; RNA, Messenger; Transplantation, Autologous; Tumor Necrosis Factor-alpha; Tunica Intima | 2008 |
Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis.
Topics: Administration, Cutaneous; Anilides; Animals; Cells, Cultured; Epidermis; Homeostasis; Humans; Hyperplasia; Keratinocytes; Male; Menthol; Mice; Mice, Hairless; Permeability; Pyrazines; Pyridines; Ruthenium Red; Skin Diseases; TRPM Cation Channels | 2010 |
Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia.
Topics: Animals; Axin Protein; beta Catenin; Boronic Acids; Bortezomib; Casein Kinase 1 epsilon; Cell Nucleus; Citrobacter rodentium; Colon; Cyclic AMP Response Element-Binding Protein; Cytoskeleton; DNA; Enterobacteriaceae Infections; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hyperplasia; Immunoprecipitation; Intestinal Mucosa; Mice; Phosphorylation; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Binding; Protein Kinase C; Pyrazines; Repressor Proteins; Serine; TCF Transcription Factors; Threonine; Transcription Factor 7-Like 2 Protein | 2007 |
Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Topics: Animals; Apoptosis; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Endothelium, Vascular; Hyperplasia; Methylmethacrylate; Platelet Aggregation Inhibitors; Polyglycolic Acid; Polymers; Proliferating Cell Nuclear Antigen; Pyrazines; Stents; Swine; Tunica Intima | 2007 |
Chemopreventive activity of oltipraz against induction of glandular stomach carcinogenesis in rats by N-methyl-N'-nitro-N-nitrosoguanidine.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Hyperplasia; Male; Methylnitronitrosoguanidine; Pylorus; Pyrazines; Rats; Rats, Wistar; Stomach Neoplasms; Thiones; Thiophenes | 1998 |
The chain of unexpected discovery: xanthopterin-stimulated renal mitosis.
Topics: Animals; Biochemistry; Creativity; History, 20th Century; Hyperplasia; Hypertrophy; Hypoxanthines; Kidney; Kidney Diseases; Mitosis; Pteridines; Purines; Pyrazines; Pyrimidines; Quinoxalines; Rats; Stimulation, Chemical; Structure-Activity Relationship; United Kingdom; Xanthine Oxidase; Xanthopterin | 1972 |